AFT-16: Phase II Trial of Neoadjuvant and adjuvant Atezolizumab (A) and Chemoradiation (CRT) for Stage III Non-small Cell Lung Cancer (NSCLC)
- Citation:
- J Clin Oncol vol 39 (no. 15_suppl) 8513
- Meeting Instance:
- ASCO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4020
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Genentech
- Grants:
- Corr. Author:
- Authors:
- Helen J. Ross David Kozono James Urbanic Terence Williams Carter Dufrane Ilze Bara Katja Schulze J. Michelle Brockman Xiaofei Wang Junheng Gao Everett E. Vokes Thomas E. Stinchcombe
- Networks:
- CA043, CA249, IL043, LAPS-IL057, LAPS-MA036, LAPS-NC010
- Study
- AFT-16
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: